Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Works matching IS 13570560 AND DT 2021 AND VI 38 AND IP 7
Results: 12
1
2
Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells.
- Published in:
- 2021
- By:
- Publication type:
- journal article
3
Correction to: Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
4
Cancer stem cell characteristics and their potential as therapeutic targets.
- Published in:
- 2021
- By:
- Publication type:
- journal article
5
Triple-arm androgen blockade for advanced prostate cancer: a review.
- Published in:
- 2021
- By:
- Publication type:
- journal article
6
Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity.
- Published in:
- 2021
- By:
- Publication type:
- journal article
7
Peripheral androgen blockade in men with castrate-sensitive biochemical recurrent prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
8
Immunotherapy era in the treatment of small cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
9
ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
10
Biological activity and molecular docking studies of some new quinolines as potent anticancer agents.
- Published in:
- 2021
- By:
- Publication type:
- journal article
11
How should we manage non-small-cell lung cancer "not-otherwise-specified"?
- Published in:
- 2021
- By:
- Publication type:
- Letter
12
Identification of key genes in the tumor microenvironment of lung adenocarcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article